AUTHOREA
Log in
Sign Up
Browse Preprints
LOG IN
SIGN UP
loading page
this is for holding javascript data
Download PDF
DOWNLOAD
Download ZIP
Download LaTeX
Download JATS XML
Track citations
Fork (make a copy)
304
1
National Medical Products Administration (NMPA) approves deuremidevir (VV116) and simnotrelvir-ritonavir for mild to moderate COVID-19 in China.
Ke-Wei Zhu
Ke-Wei Zhu
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
Corresponding Author:
[email protected]
Author Profile
03 Aug 2023
Published in ACS Pharmacology & Translational Science.
10.1021/acsptsci.3c00134
×
OK
